Dyne Therapeutics, Inc. (DYN) vs Arcus Biosciences, Inc. (RCUS)
- Dyne Therapeutics, Inc. DYN 14.25 −6.80%
- Arcus Biosciences, Inc. RCUS 22.12 −3.07%
Dyne Therapeutics, Inc. and Arcus Biosciences, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. and Arcus Biosciences, Inc. are of similar size ($2.9B and $2.9B). Dyne Therapeutics, Inc. has the higher net margin (0.00% vs −393.2%) and the lower return on invested capital (−1,956.3% vs 0.00%). Across the 14 metrics below, Dyne Therapeutics, Inc. leads on 8 and Arcus Biosciences, Inc. on 6.
Valuation
Profitability
| Metric | DYN | RCUS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (415.38%) | 0.00% |
| Net margin | 0.00% | (393.16%) | 0.00% |
| Free cash flow margin | 0.00% | (405.13%) | 0.00% |
| Return on equity | (81.57%) | (90.82%) | (56.36%) |
| Return on assets | (60.29%) | (46.02%) | (48.04%) |
| Return on invested capital | (1,956.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack